Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02204137 · ClinicalTrials.gov registry record
Falls Risk Questionnaire in Older Adults With Cancer
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 21
- Enrollment target
NCT02204137: Completed study, sponsored by Washington University School of Medicine.
NCT02204137 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02204137 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The purpose of this research study is to look at the use of a series of questionnaires evaluating risk for falls in order to collect information that might be used to develop a larger study aiming to recognize who is more at risk for falls and how to best intervene to prevent falls in older adults with cancer.
Primary Outcome
The percent of patients who complete the assessment will be calculated. Successful completion will be defined as the completion of all items on the questionnaires. If more than 85% of subjects are able to complete the FRQ and CARG GA, the assessment will be deemed feasible.
Interventions
- OTHER Falls Risk Questionnaire
- OTHER Cancer and Aging Research Group Geriatric Assessment
- OTHER Falls Efficacy Scale-International (FES-1)
- OTHER Health Related Quality of Life using the Functional Assessment of Cancer Therapy - Gynecologic Oncology Group Neurotoxicity Scale (FACT GOG/NTX)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2014-08 |
| Est. Completion | 2014-11 |
What the finished NCT02204137 record still lists
NCT02204137 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Falls Risk Questionnaire is the first listed.
NCT02204137 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02204137 about?
NCT02204137 is a clinical study titled "Falls Risk Questionnaire in Older Adults With Cancer". The purpose of this research study is to look at the use of a series of questionnaires evaluating risk for falls in order to collect information that might be used to develop a larger study aiming to recognize who is more at risk for falls and how to best intervene to prevent falls in older adults w...
What is the current status of trial NCT02204137?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2014-08. Estimated completion is 2014-11.
What interventions are being tested in trial NCT02204137?
The interventions under investigation include: Falls Risk Questionnaire (OTHER), Cancer and Aging Research Group Geriatric Assessment (OTHER), Falls Efficacy Scale-International (FES-1) (OTHER), Health Related Quality of Life using the Functional Assessment of Cancer Therapy - Gynecologic Oncology Group Neurotoxicity Scale (FACT GOG/NTX) (OTHER).
Who is sponsoring clinical trial NCT02204137?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia